Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin - PubMed (original) (raw)
. 2005 Sep 2;280(35):30773-82.
doi: 10.1074/jbc.M504749200. Epub 2005 Jun 27.
Affiliations
- PMID: 15983033
- DOI: 10.1074/jbc.M504749200
Free article
Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin
Tamara Milakovic et al. J Biol Chem. 2005.
Free article
Abstract
There is significant evidence that energy production impairment and mitochondrial dysfunction play a role in the pathogenesis of Huntington disease. Nonetheless, the specific mitochondrial defects due to the presence of mutant huntingtin have not been fully elucidated. To determine the effects of mutant huntingtin on mitochondrial energy production, a thorough analysis of respiration, ATP production, and functioning of the respiratory complexes was carried out in clonal striatal cells established from Hdh(Q7) (wild-type) and Hdh(Q111) (mutant huntingtin knock-in) mouse embryos. Mitochondrial respiration and ATP production were significantly reduced in the mutant striatal cells compared with the wild-type cells when either glutamate/malate or succinate was used as the substrate. However, mitochondrial respiration was similar in the two cell lines when the artificial electron donor TMPD/ascorbate, which feeds into complex IV, was used as the substrate. The attenuation of mitochondrial respiration and ATP production when either glutamate/malate or succinate was used as the substrate was not due to impairment of the respiratory complexes, because their activities were equivalent in both cell lines. Intriguingly, in the striatum of presymptomatic and pathological grade 1 Huntington disease cases there is also no impairment of mitochondrial complexes I-IV (Guidetti, P., Charles, V., Chen, E. Y., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Jr., Schwarcz, R., and Tagle, D. A. (2001) Exp. Neurol. 169, 340-350). To our knowledge, this is the first comprehensive analysis of the effects of physiological levels of mutant huntingtin on mitochondrial respiratory function within an appropriate cellular context. These findings demonstrate that the presence of mutant huntingtin impairs mitochondrial ATP production through one or more mechanisms that do not directly affect the function of the respiration complexes.
Similar articles
- Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
Oliveira JM. Oliveira JM. J Neurochem. 2010 Jul;114(1):1-12. doi: 10.1111/j.1471-4159.2010.06741.x. Epub 2010 Apr 9. J Neurochem. 2010. PMID: 20403078 Review. - Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.
Reis SA, Thompson MN, Lee JM, Fossale E, Kim HH, Liao JK, Moskowitz MA, Shaw SY, Dong L, Haggarty SJ, MacDonald ME, Seong IS. Reis SA, et al. Hum Mol Genet. 2011 Jun 15;20(12):2344-55. doi: 10.1093/hmg/ddr127. Epub 2011 Mar 29. Hum Mol Genet. 2011. PMID: 21447599 Free PMC article. - Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway.
Ruan Q, Lesort M, MacDonald ME, Johnson GV. Ruan Q, et al. Hum Mol Genet. 2004 Apr 1;13(7):669-81. doi: 10.1093/hmg/ddh082. Epub 2004 Feb 12. Hum Mol Genet. 2004. PMID: 14962977 - Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.
Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P, Déglon N, Brouillet E. Benchoua A, et al. Mol Biol Cell. 2006 Apr;17(4):1652-63. doi: 10.1091/mbc.e05-07-0607. Epub 2006 Feb 1. Mol Biol Cell. 2006. PMID: 16452635 Free PMC article. - Mitochondria in Huntington's disease.
Damiano M, Galvan L, Déglon N, Brouillet E. Damiano M, et al. Biochim Biophys Acta. 2010 Jan;1802(1):52-61. doi: 10.1016/j.bbadis.2009.07.012. Epub 2009 Aug 11. Biochim Biophys Acta. 2010. PMID: 19682570 Review.
Cited by
- trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.
Fu J, Jin J, Cichewicz RH, Hageman SA, Ellis TK, Xiang L, Peng Q, Jiang M, Arbez N, Hotaling K, Ross CA, Duan W. Fu J, et al. J Biol Chem. 2012 Jul 13;287(29):24460-72. doi: 10.1074/jbc.M112.382226. Epub 2012 May 30. J Biol Chem. 2012. PMID: 22648412 Free PMC article. - Taming the Huntington's Disease Proteome: What Have We Learned?
Seeley C, Kegel-Gleason KB. Seeley C, et al. J Huntingtons Dis. 2021;10(2):239-257. doi: 10.3233/JHD-200465. J Huntingtons Dis. 2021. PMID: 33998547 Free PMC article. Review. - Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.
Chaturvedi RK, Calingasan NY, Yang L, Hennessey T, Johri A, Beal MF. Chaturvedi RK, et al. Hum Mol Genet. 2010 Aug 15;19(16):3190-205. doi: 10.1093/hmg/ddq229. Epub 2010 Jun 7. Hum Mol Genet. 2010. PMID: 20529956 Free PMC article. - Mitochondrial Protection by PARP Inhibition.
Gallyas F Jr, Sumegi B. Gallyas F Jr, et al. Int J Mol Sci. 2020 Apr 16;21(8):2767. doi: 10.3390/ijms21082767. Int J Mol Sci. 2020. PMID: 32316192 Free PMC article. Review. - Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration.
Knott AB, Bossy-Wetzel E. Knott AB, et al. Ann N Y Acad Sci. 2008 Dec;1147:283-92. doi: 10.1196/annals.1427.030. Ann N Y Acad Sci. 2008. PMID: 19076450 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources